Experimental: Baofukang Suppository 7 daysExperimental: Baofukang Suppository 14 days
Experimental: Baofukang Suppository 7 days: Experimental: Baofukang Suppository 7 days
Experimental: Baofukang Suppository 14 days: Experimental: Baofukang Suppository 14 days
Study summary
Aerobic vaginitis was treated by using Baofukang Suppository 7 days group or Baofukang Suppository 14 days group.To evaluate the efficacy and safety after treatment.
Eligibility
Sex
FEMALE
Min age
18 Years
Max age
55 Years
Healthy volunteers
No
Inclusion Criteria:
Aerobic vaginitis diagnosed based on present ：
1. Vaginal dischareg ;
2. pH \> 4.5;
3. Donders score≥3;
Exclusion Criteria:
1. Patients with other vaginitis, cervical erosion, or suspected gonorrhea, herpes simplex virus infection and other vulvar diseases;
2. Patients received systemic or vaginal antifungal or antibiotic treatment within two weeks before admission.
3. Pregnancy, lactation and intentional pregnancy;
4. Women with liver and kidney dysfunction, low immune function, diabetes, psychosis or other serious diseases;
5. Allergic constitution and patients allergic to drug ingredients in this study;
6. Those with poor compliance.
Primary outcome measure(s)
Cure rate — First week after treatment A vaginal smear composite Donders score of 1 to 2 represents normality. A score of more than 2 is aerobic vaginitis. There are four variables(Lactobacillary; leucocytes; toxic leukocytes; parabasal cells; background flora). Detail see references Links.
Cure rate — First month after the treatment A vaginal smear composite Donders score of 1 to 2 represents normality. A score of more than 2 is aerobic vaginitis. There are four variables(Lactobacillary; leucocytes; toxic leukocytes; parabasal cells; background flora).Detail see folowing references.
Trial sites (1)
Facility
City
Region
Status
Peking University Shenzhen Hosptal
Shenzhen
Guangdong
Recruiting
More Peking University Shenzhen Hospital trials in China
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time on our Cookie Policy page. See also our Privacy Policy.